These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37432855)

  • 21. CRISPR/Cas9-mediated tissue-specific knockout and cDNA rescue using sgRNAs that target exon-intron junctions in
    Chilian M; Vargas Parra K; Sandoval A; Ramirez J; Yoon WH
    STAR Protoc; 2022 Sep; 3(3):101465. PubMed ID: 35719725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR deactivation in mammalian cells using photocleavable guide RNAs.
    Zou RS; Liu Y; Ha T
    STAR Protoc; 2021 Dec; 2(4):100909. PubMed ID: 34746867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of
    Pelletier S; Tummers B; Green DR
    STAR Protoc; 2020 Dec; 1(3):100181. PubMed ID: 33377075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orthotopic T-cell receptor replacement in primary human T cells using CRISPR-Cas9-mediated homology-directed repair.
    Moosmann C; Müller TR; Busch DH; Schober K
    STAR Protoc; 2022 Mar; 3(1):101031. PubMed ID: 34977677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRISPR-Cas9-Mediated Genomic Deletions Protocol in Zebrafish.
    Amorim JP; Bordeira-Carriço R; Gali-Macedo A; Perrod C; Bessa J
    STAR Protoc; 2020 Dec; 1(3):100208. PubMed ID: 33377102
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient CRISPR-Cas9-mediated genome editing for characterization of essential genes in
    Picchi-Constante GFA; Hiraiwa PM; Marek M; Rogerio VZ; Guerra-Slompo EP; Romier C; Zanchin NIT
    STAR Protoc; 2022 Jun; 3(2):101324. PubMed ID: 35496799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute gene inactivation in the adult mouse liver using the CRISPR-Cas9 technology.
    Wang X; Xu BL; Chen XW
    STAR Protoc; 2021 Sep; 2(3):100611. PubMed ID: 34189476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimized protocol for gene editing in adipocytes using CRISPR-Cas9 technology.
    Qiu Y; Ding Q
    STAR Protoc; 2021 Mar; 2(1):100307. PubMed ID: 33554142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific and efficient gene knockout and overexpression in mouse interscapular brown adipocytes in vivo.
    Xue K; Wu D; Qiu Y
    STAR Protoc; 2022 Dec; 3(4):101895. PubMed ID: 36595932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploiting CRISPR/Cas9 to engineer precise segmental deletions in mouse embryonic stem cells.
    Elango R; Panday A; Willis NA; Scully R
    STAR Protoc; 2022 Sep; 3(3):101551. PubMed ID: 36042887
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FACS-assisted CRISPR-Cas9 genome editing of human induced pluripotent stem cells.
    Caillaud A; Lévêque A; Thédrez A; Girardeau A; Canac R; Bray L; Baudic M; Barc J; Gaborit N; Lamirault G; Gardie B; Idriss S; Rimbert A; Le May C; Cariou B; Si-Tayeb K
    STAR Protoc; 2022 Dec; 3(4):101680. PubMed ID: 36115027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimized CRISPR/Cas9-mediated single nucleotide mutation in adherent cancer cell lines.
    Gao P; Dong X; Wang Y; Wei GH
    STAR Protoc; 2021 Jun; 2(2):100419. PubMed ID: 33870225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generating mutant
    Li HH; Li JC; Su MP; Liu KL; Chen CH
    STAR Protoc; 2021 Jun; 2(2):100432. PubMed ID: 33899015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heritable CRISPR-Cas9 editing of plant genomes using RNA virus vectors.
    Uranga M; Aragonés V; Daròs JA; Pasin F
    STAR Protoc; 2023 Mar; 4(1):102091. PubMed ID: 36853698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation and CRISPR-Cas9-mediated genetic engineering of human intestinal organoids.
    Martinez-Silgado A; Yousef Yengej FA; Puschhof J; Geurts V; Boot C; Geurts MH; Rookmaaker MB; Verhaar MC; Beumer J; Clevers H
    STAR Protoc; 2022 Sep; 3(3):101639. PubMed ID: 36042877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimized electroporation of CRISPR-Cas9/gRNA ribonucleoprotein complex for selection-free homologous recombination in human pluripotent stem cells.
    Xu H; Kita Y; Bang U; Gee P; Hotta A
    STAR Protoc; 2021 Dec; 2(4):100965. PubMed ID: 34825222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protocol for genome-wide CRISPR knockout screens of bacterial cytotoxins in HeLa cells.
    Yang Q; Zhou Y; He L; Zhang Y; Tao L
    STAR Protoc; 2022 Sep; 3(3):101595. PubMed ID: 35928004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRISPR-Cas9-mediated induction of large chromosomal inversions in human bronchial epithelial cells.
    Angelopoulou A; Papaspyropoulos A; Papantonis A; Gorgoulis VG
    STAR Protoc; 2022 Jun; 3(2):101257. PubMed ID: 35330963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Robust Protocol for CRISPR-Cas9 Gene Editing in Human Suspension Cell Lines.
    Wardyn JD; Chan ASY; Jeyasekharan AD
    Curr Protoc; 2021 Nov; 1(11):e286. PubMed ID: 34748280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CRISPR screen to determine the
    Sangaré LO; Wang Y; Arranz-Solís D; Saeij JPJ
    STAR Protoc; 2021 Jun; 2(2):100520. PubMed ID: 34013213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.